Recurrent Rhegmatogenous Retinal Detachment: Characteristics, Risk Factors, and Outcomes.

IF 2.8 3区 医学 Q1 Pharmacology, Toxicology and Pharmaceutics
Therapeutics and Clinical Risk Management Pub Date : 2025-04-01 eCollection Date: 2025-01-01 DOI:10.2147/TCRM.S506037
Abdelwahab Aleshawi, Rami Al-Dwairi, Omar A Saleh, Sharaf Adi, Seren Al Beiruti, Acil Alasheh, Mohammad A Alsaadi, Zakaria H Ouda, Mohammed Z Allouh
{"title":"Recurrent Rhegmatogenous Retinal Detachment: Characteristics, Risk Factors, and Outcomes.","authors":"Abdelwahab Aleshawi, Rami Al-Dwairi, Omar A Saleh, Sharaf Adi, Seren Al Beiruti, Acil Alasheh, Mohammad A Alsaadi, Zakaria H Ouda, Mohammed Z Allouh","doi":"10.2147/TCRM.S506037","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Rhegmatogenous retinal detachment (RRD) is a severe retinal disorder that can lead to vision impairment and potentially blindness. After RRD repair surgery, every vitreoretinal surgeon aims to understand the characteristics of the RRD and to achieve permanent flattening without any recurrence. This study aimed to identify factors predisposing patients to recurrent RRD.</p><p><strong>Patients and methods: </strong>This retrospective study was conducted at King Abdullah University Hospital and included all patients who underwent pars plana vitrectomy for RRD repair between January 2015 and December 2023. All demographic, clinical, operative, and outcome data were extracted. The primary outcome was to assess the risk factors affecting the recurrence of RRD. The secondary outcome included factors affecting the final status (flat or detached) of the retina. Using proper statistical methods, the results were generated.</p><p><strong>Results: </strong>The study comprised 348 patients with primary RRD, of whom 44.5% had a previous ocular surgical history. The rate of recurrent RRD was 28.2%. At the last follow-up, 12.6% of the whole patients had persistent retinal detachment without anatomical successful reattachment. Superior-based RRD was the most common type, affecting 145 of 290 patients, and macular involvement in the RRD was observed in 80% of the cases. Recurrent RRD was higher in younger ages, longer duration of symptoms, extensive total type of RRD, involvement of inferior quadrants, detached macula, presence of proliferative vitreoretinopathy, and insufficient prophylactic laser retinopexy (p < 0.05). On multivariate logistic analysis, extensive total RRD, presentation duration, and insufficient prophylactic laser retinopexy were considered as a significant independent factor.</p><p><strong>Conclusion: </strong>Duration of symptoms, involvement of more quadrants, and insufficient laser retinopexy could influence RRD recurrence. These results may coincide with previous literature but provide insights into the newly investigated population. Increasing the awareness of RRD symptoms, identifying high-risk patients, and ensuring prompt surgical intervention may reduce RRD-related complications and decrease the rate of recurrence.</p>","PeriodicalId":22977,"journal":{"name":"Therapeutics and Clinical Risk Management","volume":"21 ","pages":"425-440"},"PeriodicalIF":2.8000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11971961/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Therapeutics and Clinical Risk Management","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/TCRM.S506037","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: Rhegmatogenous retinal detachment (RRD) is a severe retinal disorder that can lead to vision impairment and potentially blindness. After RRD repair surgery, every vitreoretinal surgeon aims to understand the characteristics of the RRD and to achieve permanent flattening without any recurrence. This study aimed to identify factors predisposing patients to recurrent RRD.

Patients and methods: This retrospective study was conducted at King Abdullah University Hospital and included all patients who underwent pars plana vitrectomy for RRD repair between January 2015 and December 2023. All demographic, clinical, operative, and outcome data were extracted. The primary outcome was to assess the risk factors affecting the recurrence of RRD. The secondary outcome included factors affecting the final status (flat or detached) of the retina. Using proper statistical methods, the results were generated.

Results: The study comprised 348 patients with primary RRD, of whom 44.5% had a previous ocular surgical history. The rate of recurrent RRD was 28.2%. At the last follow-up, 12.6% of the whole patients had persistent retinal detachment without anatomical successful reattachment. Superior-based RRD was the most common type, affecting 145 of 290 patients, and macular involvement in the RRD was observed in 80% of the cases. Recurrent RRD was higher in younger ages, longer duration of symptoms, extensive total type of RRD, involvement of inferior quadrants, detached macula, presence of proliferative vitreoretinopathy, and insufficient prophylactic laser retinopexy (p < 0.05). On multivariate logistic analysis, extensive total RRD, presentation duration, and insufficient prophylactic laser retinopexy were considered as a significant independent factor.

Conclusion: Duration of symptoms, involvement of more quadrants, and insufficient laser retinopexy could influence RRD recurrence. These results may coincide with previous literature but provide insights into the newly investigated population. Increasing the awareness of RRD symptoms, identifying high-risk patients, and ensuring prompt surgical intervention may reduce RRD-related complications and decrease the rate of recurrence.

复发性风湿性视网膜脱离:特征、风险因素和结果。
目的:孔源性视网膜脱离(RRD)是一种严重的视网膜疾病,可导致视力损害和潜在失明。在RRD修复手术后,每个玻璃体视网膜外科医生的目标都是了解RRD的特征,实现永久变平而不复发。本研究旨在确定患者复发性RRD的易感性因素。患者和方法:这项回顾性研究在阿卜杜拉国王大学医院进行,纳入了2015年1月至2023年12月期间所有接受玻璃体切割手术进行RRD修复的患者。提取所有人口统计学、临床、手术和结局数据。主要结局是评估影响RRD复发的危险因素。次要结局包括影响视网膜最终状态(扁平或脱离)的因素。使用适当的统计方法,生成结果。结果:本研究纳入348例原发性RRD患者,其中44.5%有眼部手术史。复发率为28.2%。在最后一次随访中,12.6%的患者有持续性视网膜脱离,但没有解剖上成功的再附着。基于superior的RRD是最常见的类型,影响了290例患者中的145例,80%的病例观察到RRD的黄斑受累。RRD复发的年龄越小、症状持续时间越长、RRD类型广泛、下象限受累、黄斑脱落、存在增殖性玻璃体视网膜病变、预防性激光视网膜固定术不充分(p < 0.05)。在多因素logistic分析中,广泛的总RRD、出现时间和不充分的预防性激光视网膜固定被认为是重要的独立因素。结论:症状持续时间、累及象限多、激光视网膜固定不充分等因素可能影响RRD的复发。这些结果可能与以前的文献一致,但为新调查的人群提供了见解。提高对RRD症状的认识,识别高危患者,确保及时进行手术干预,可减少RRD相关并发症,降低复发率。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Therapeutics and Clinical Risk Management
Therapeutics and Clinical Risk Management HEALTH CARE SCIENCES & SERVICES-
CiteScore
5.30
自引率
3.60%
发文量
139
审稿时长
16 weeks
期刊介绍: Therapeutics and Clinical Risk Management is an international, peer-reviewed journal of clinical therapeutics and risk management, focusing on concise rapid reporting of clinical studies in all therapeutic areas, outcomes, safety, and programs for the effective, safe, and sustained use of medicines, therapeutic and surgical interventions in all clinical areas. The journal welcomes submissions covering original research, clinical and epidemiological studies, reviews, guidelines, expert opinion and commentary. The journal will consider case reports but only if they make a valuable and original contribution to the literature. As of 18th March 2019, Therapeutics and Clinical Risk Management will no longer consider meta-analyses for publication. The journal does not accept study protocols, animal-based or cell line-based studies.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信